REFERENCES
- Jarvis WR, Martone WJ. Predominant pathogens in hos-pital infections. J Antimicrob Chemother, 1992; 29 (Suppl A): 19-24.
- Fantin B, Leclercq R, Duval J, Carbon C. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother, 1993; 37: 2466–9.
- Kloss WE, Bannerman TL. Update on clinical signifi-cance of coagulase-negative staphylococci. Clin Microbiol Rev, 1994; 7: 117–40.
- Rupp ME, Archer GL. Coagulase-negative staphylococ-ci: pathogens associated with medical progress. Clin Infect Dis, 1994; 19: 231–45.
- Hackbarth CJ, Chambers HF. Methicillin-resistant staphylococci: detection methods and treatment of infections. Antimicrob Agents Chemother, 1989; 33: 995–9.
- National Committee for Clinical Laboratory Standards. Approved Standards. M 7-A3. Methods for dilution antimicro-bial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, PA. 1993.
- Krogstad DJ, Moellering RC Jr. Antibiotics in Laboratory Medecine. In: Lorian V ed. Antimicrobial combi-nations. Baltimore: Williams & Wilkins, 1986: 537–78.
- Eliopoulos GM, Moellering RC Jr. Antibiotics in Laboratory Medecine. In: Lorian V ed. Antimicrobial combi-nations. Baltimore: Williams & Wilkins, 1991: 432–92.
- Hammerberg O, Gittens C. Synergistic studies on coag-ulase positive and negative staphylococci using fusidic acid. In: Ishigami J. ed. Recent advances in chemotherapy. Proceedings of the 14th International Congress of Chemotherapy. Antimicrobial Section I. Tokyo: University of Tokyo Press, 1985: 462-63.
- Besnier JM, Kanoun F, Martin C, Cotty P, Fenneteau A, Choutet P. Failure of a combination of vancomycin and fusidic acid in a patient with staphylococcal infection. J Antimicrob Chemother, 1991; 27: 560–562.
- Coombs RRH. Fusidic acid in staphylococcal bone and joint infection. J Antimicrobial Chemother, 1990; 25 (Suppl B): 53-60.
- Kropec A, Daschner FD. Penetration into tissues of various drugs active against Gram-positive bacteria. J Antimicrob Chemother, 1991; 27 (Suppl B): 9-15.
- Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus. Antimicrob Agents Chemother, 1995; 39: 2289–94.